topotecan
Showing 1 - 25 of 461
Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Topotecan)
Not yet recruiting
- Small Cell Lung Carcinoma (SCLC)
- BI 764532
- Topotecan
- (no location specified)
Aug 7, 2023
Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)
Not yet recruiting
- Extensive-stage Small-cell Lung Cancer
- Trilaciclib
- +2 more
- (no location specified)
May 22, 2023
Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)
Not yet recruiting
- Platinum-resistant Ovarian Cancer
- Oral Topotecan Combined With Anlotinib
-
Shanghai, ChinaXinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023
Brain and CNS Tumors Trial in Chicago (thalidomide, topotecan HCl)
Terminated
- Brain and Central Nervous System Tumors
- thalidomide
- topotecan hydrochloride
-
Chicago, IllinoisRush Cancer Institute at Rush University Medical Center
Jan 5, 2023
Platinum-Resistant Lung Small Cell Carcinoma, Platinum-Sensitive Lung Small Cell Carcinoma, Recurrent Extensive Stage Lung Small
Recruiting
- Platinum-Resistant Lung Small Cell Carcinoma
- +3 more
- Durvalumab
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Carboplatin
- +3 more
-
Los Angeles, California
- +5 more
Jan 27, 2023
Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)
Not yet recruiting
- Relapsed Small Cell Lung Cancer
- Irinotecan hydrochloride liposome Injection
- Topotecan
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023
Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Platinum-Resistant Lung Small Cell Carcinoma
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- +3 more
- Biopsy
- +4 more
-
Los Angeles, California
- +8 more
Jan 31, 2023
Gliomas Trial in New York (Topotecan, Gadolinium, Synchromed II infusion pumps)
Completed
- Gliomas
- Topotecan
- +2 more
-
New York, New YorkColumbia University Irving Medical Center
Jun 30, 2022
Advanced Solid Tumors Trial in United States (FF-10850 Topotecan Liposome Injection)
Recruiting
- Advanced Solid Tumors
- FF-10850 Topotecan Liposome Injection
-
Scottsdale, Arizona
- +5 more
Oct 19, 2022
Neuroblastoma Trial (Topotecan, Temozolomide, Ribociclib)
Not yet recruiting
- Neuroblastoma
- Topotecan
- +2 more
- (no location specified)
Jun 17, 2022
Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))
Completed
- Malignant Glioma
- +2 more
- Bevacizumab
- +3 more
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022
Solid Tumors Trial in Canada (Topotecan and Pazopanib)
Completed
- Solid Tumors
- Topotecan and Pazopanib
-
Calgary, Alberta, Canada
- +9 more
Jun 27, 2022
Neuroblastoma Trial in Canada, United States (Sorafenib, Cyclophosphamide, Topotecan)
Active, not recruiting
- Neuroblastoma
- Sorafenib
- +2 more
-
Los Angeles, California
- +11 more
Jan 30, 2023
Metastatic Malignant Solid Tumor, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in United States
Active, not recruiting
- Metastatic Malignant Solid Neoplasm
- +4 more
- Laboratory Biomarker Analysis
- +4 more
-
Phoenix, Arizona
- +14 more
Sep 1, 2022
Ovarian Cancer, Peritoneal Tumors, Fallopian Tube Cancer Trial in Houston (Topotecan, Gefitinib)
Completed
- Ovarian Cancer
- +2 more
- Topotecan
- Gefitinib
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 11, 2022
COVID-19 Respiratory Infection Trial in Vellore (Topotecan)
Recruiting
- COVID-19 Respiratory Infection
- Topotecan
-
Vellore, Tamil Nadu, IndiaChristian Medical College
Oct 27, 2021
Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)
Recruiting
- Neuroblastoma
- Pediatric Cancer
- Cyclophosphamide
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 11, 2023
Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma, Relapsed Osteosarcoma Trial in Boston (Cabozantinib, Topotecan,
Recruiting
- Relapsed Ewing Sarcoma
- +3 more
- Cabozantinib
- +3 more
-
Boston, Massachusetts
- +1 more
Sep 27, 2021
Advanced Cancer Trial in Houston (FLT-PET)
Completed
- Advanced Cancer
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 3, 2022
Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Phoenix,
Recruiting
- Recurrent Fallopian Tube Carcinoma
- +2 more
- Bevacizumab
- +4 more
-
Phoenix, Arizona
- +2 more
Jun 27, 2022
Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- Induction Chemotherapy
- +3 more
-
Palo Alto, California
- +5 more
Nov 29, 2022